{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:00:38Z","timestamp":1777564838143,"version":"3.51.4"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["595"],"award-info":[{"award-number":["595"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["595"],"award-info":[{"award-number":["595"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["595"],"award-info":[{"award-number":["595"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["595"],"award-info":[{"award-number":["595"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["595"],"award-info":[{"award-number":["595"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["595"],"award-info":[{"award-number":["595"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["595"],"award-info":[{"award-number":["595"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["595"],"award-info":[{"award-number":["595"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["595"],"award-info":[{"award-number":["595"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["595"],"award-info":[{"award-number":["595"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["595"],"award-info":[{"award-number":["595"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["595"],"award-info":[{"award-number":["595"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["595"],"award-info":[{"award-number":["595"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["595"],"award-info":[{"award-number":["595"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["595"],"award-info":[{"award-number":["595"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12026-025-09598-6","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T21:29:37Z","timestamp":1739395777000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Immunization with recombinant HPV16-E7d in fusion with Flagellin as a cancer vaccine: Effect of antigen-adjuvant orientation on the immune response pattern"],"prefix":"10.1007","volume":"73","author":[{"given":"Meysam","family":"Gachpazan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Ahmadnia","family":"Alashti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid Reza","family":"Jahantigh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Moghbeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sobhan","family":"Faezi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Younes","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Mahdi","family":"Eftekharian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Nasimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad Motavalli","family":"Khiavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza Arabi","family":"Mianroodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Pakjoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morteza","family":"Taghizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Tempesta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4478-5957","authenticated-orcid":false,"given":"Mehdi","family":"Mahdavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"9598_CR1","first-page":"251","volume":"119","author":"N Munoz","year":"1991","unstructured":"Munoz N, Bosch F. HPV and cervical neoplasia: review of case-control and cohort studies. IARC Sci Publ. 1991;119:251\u201361.","journal-title":"IARC Sci Publ"},{"key":"9598_CR2","doi-asserted-by":"publisher","first-page":"552028","DOI":"10.3389\/fpubh.2020.552028","volume":"8","author":"AJ KombeKombe","year":"2020","unstructured":"KombeKombe AJ, Li B, Zahid A, Mengist HM, Bounda GA, Zhou Y, et al. Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation. Front Public Health. 2020;8:552028. https:\/\/doi.org\/10.3389\/fpubh.2020.552028.","journal-title":"Front Public Health"},{"issue":"4","key":"9598_CR3","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ijc.30716","volume":"141","author":"C de Martel","year":"2017","unstructured":"de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664\u201370. https:\/\/doi.org\/10.1002\/ijc.30716.","journal-title":"Int J Cancer"},{"issue":"23","key":"9598_CR4","doi-asserted-by":"publisher","first-page":"10053","DOI":"10.7314\/APJCP.2014.15.23.10053","volume":"15","author":"JG Yildirim","year":"2013","unstructured":"Yildirim JG, Arabaci Z. Innovations in HPV vaccination and roles of nurses in cervical cancer prevention. Asian Pac J Cancer Prev: APJCP. 2013;15(23):10053\u20136.","journal-title":"Asian Pac J Cancer Prev: APJCP"},{"issue":"7","key":"9598_CR5","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/ijc.24116","volume":"124","author":"H De Vuyst","year":"2009","unstructured":"De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta-analysis. Int J Cancer. 2009;124(7):1626\u201336.","journal-title":"Int J Cancer"},{"issue":"14","key":"9598_CR6","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.vaccine.2013.10.081","volume":"32","author":"C Dochez","year":"2014","unstructured":"Dochez C, Bogers JJ, Verhelst R, Rees H. HPV vaccines to prevent cervical cancer and genital warts: an update. Vaccine. 2014;32(14):1595\u2013601.","journal-title":"Vaccine"},{"issue":"3","key":"9598_CR7","doi-asserted-by":"publisher","first-page":"2289242","DOI":"10.1080\/21645515.2023.2289242","volume":"19","author":"N Bhatla","year":"2023","unstructured":"Bhatla N, Muwonge R, Malvi SG, Joshi S, Poli URR, Lucas E, et al. Impact of age at vaccination and cervical HPV infection status on binding and neutralizing antibody titers at 10 years after receiving single or higher doses of quadrivalent HPV vaccine. Hum Vaccin Immunother. 2023;19(3):2289242. https:\/\/doi.org\/10.1080\/21645515.2023.2289242.","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"9598_CR8","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1136\/jcp.2007.052027","volume":"61","author":"L-W Huang","year":"2008","unstructured":"Huang L-W, Chao S-L, Lee B-H. Integration of human papillomavirus type-16 and type-18 is a very early event in cervical carcinogenesis. J Clin Pathol. 2008;61(5):627\u201331.","journal-title":"J Clin Pathol"},{"issue":"4","key":"9598_CR9","doi-asserted-by":"publisher","first-page":"e1000397","DOI":"10.1371\/journal.ppat.1000397","volume":"5","author":"M Kadaja","year":"2009","unstructured":"Kadaja M, Isok-Paas H, Laos T, Ustav E, Ustav M. Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses. PLoS Pathog. 2009;5(4):e1000397.","journal-title":"PLoS Pathog"},{"issue":"4","key":"9598_CR10","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/path.2192","volume":"212","author":"M Pett","year":"2007","unstructured":"Pett M, Coleman N. Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis? J Pathol. 2007;212(4):356\u201367.","journal-title":"J Pathol"},{"issue":"10","key":"9598_CR11","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1038\/sj.emboj.7600651","volume":"24","author":"MS Longworth","year":"2005","unstructured":"Longworth MS, Wilson R, Laimins LA. HPV31 E7 facilitates replication by activating E2F2 transcription through its interaction with HDACs. EMBO J. 2005;24(10):1821\u201330.","journal-title":"EMBO J"},{"issue":"49","key":"9598_CR12","doi-asserted-by":"publisher","first-page":"19541","DOI":"10.1073\/pnas.0707947104","volume":"104","author":"CA Moody","year":"2007","unstructured":"Moody CA, Fradet-Turcotte A, Archambault J, Laimins LA. Human papillomaviruses activate caspases upon epithelial differentiation to induce viral genome amplification. Proc Natl Acad Sci. 2007;104(49):19541\u20136.","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"9598_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1177\/135965350701200417","volume":"12","author":"A Fradet-Turcotte","year":"2006","unstructured":"Fradet-Turcotte A, Archambault J. Recent advances in the search for antiviral agents against human papillomaviruses. Antivir Ther. 2006;12(4):431\u201351.","journal-title":"Antivir Ther"},{"issue":"1","key":"9598_CR14","doi-asserted-by":"publisher","first-page":"22634","DOI":"10.1038\/s41598-023-49441-2","volume":"13","author":"P Rocha Martins","year":"2023","unstructured":"Rocha Martins P, Luciano Pereira Morais K, de Lima Galdino NA, Jacauna A, Paula SOC, Magalh\u00e3es WCS, et al. Linking tumor immune infiltrate and systemic immune mediators to treatment response and prognosis in advanced cervical cancer. Sci Rep. 2023;13(1):22634. https:\/\/doi.org\/10.1038\/s41598-023-49441-2.","journal-title":"Sci Rep"},{"issue":"1","key":"9598_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/vaccines10010053","volume":"10","author":"A Akhatova","year":"2021","unstructured":"Akhatova A, Chan CK, Azizan A, Aimagambetova G. The Efficacy of Therapeutic DNA Vaccines Expressing the Human Papillomavirus E6 and E7 Oncoproteins for Treatment of Cervical Cancer: Systematic Review. Vaccines (Basel). 2021;10(1):53. https:\/\/doi.org\/10.3390\/vaccines10010053.","journal-title":"Vaccines (Basel)"},{"issue":"6","key":"9598_CR16","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/sj.icb.7100102","volume":"85","author":"AJ Gearing","year":"2007","unstructured":"Gearing AJ. Targeting toll-like receptors for drug development: a summary of commercial approaches. Immunol Cell Biol. 2007;85(6):490\u20134.","journal-title":"Immunol Cell Biol"},{"issue":"1","key":"9598_CR17","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1600-065X.2010.00978.x","volume":"239","author":"MS Duthie","year":"2011","unstructured":"Duthie MS, Windish HP, Fox CB, Reed SG. Use of defined TLR ligands as adjuvants within human vaccines. Immunol Rev. 2011;239(1):178\u201396.","journal-title":"Immunol Rev"},{"issue":"1","key":"9598_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1600-065X.2008.00731.x","volume":"227","author":"NW Palm","year":"2009","unstructured":"Palm NW, Medzhitov R. Pattern recognition receptors and control of adaptive immunity. Immunol Rev. 2009;227(1):221\u201333.","journal-title":"Immunol Rev"},{"issue":"11","key":"9598_CR19","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1099\/jmm.0.000174","volume":"64","author":"S Delavari","year":"2015","unstructured":"Delavari S, Sohrabi M, Ardestani MS, Faezi S, Tebianian M, Taghizadeh M, et al. Pseudomonas aeruginosa flagellin as an adjuvant: superiority of a conjugated form of flagellin versus a mixture with a human immunodeficiency virus type 1 vaccine candidate in the induction of immune responses. J Med Microbiol. 2015;64(11):1361\u20138.","journal-title":"J Med Microbiol"},{"issue":"10","key":"9598_CR20","doi-asserted-by":"publisher","first-page":"5677","DOI":"10.4049\/jimmunol.1002156","volume":"185","author":"SB Mizel","year":"2010","unstructured":"Mizel SB, Bates JT. Flagellin as an adjuvant: cellular mechanisms and potential. J Immunol. 2010;185(10):5677\u201382.","journal-title":"J Immunol"},{"issue":"4","key":"9598_CR21","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3390\/vaccines1040415","volume":"1","author":"S Nystr\u00f6m","year":"2013","unstructured":"Nystr\u00f6m S, Br\u00e5ve A, Falkeborn T, Devito C, Rissiek B, Johansson DX, et al. DNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-Adjuvant. Vaccines. 2013;1(4):415\u201343.","journal-title":"Vaccines"},{"issue":"5","key":"9598_CR22","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1128\/IAI.72.5.2810-2816.2004","volume":"72","author":"C Cuadros","year":"2004","unstructured":"Cuadros C, Lopez-Hernandez FJ, Dominguez AL, McClelland M, Lustgarten J. Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses. Infect Immun. 2004;72(5):2810\u20136.","journal-title":"Infect Immun"},{"issue":"1","key":"9598_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0264-410X(95)00088-I","volume":"14","author":"R Levi","year":"1996","unstructured":"Levi R, Arnon R. Synthetic recombinant influenza vaccine induces efficient long-term immunity and cross-strain protection. Vaccine. 1996;14(1):85\u201392.","journal-title":"Vaccine"},{"issue":"6","key":"9598_CR24","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/cmi.2011.24","volume":"8","author":"H Zhang","year":"2011","unstructured":"Zhang H, Liu L, Wen K, Huang J, Geng S, Shen J, et al. Chimeric flagellin expressed by Salmonella typhimurium induces an ESAT-6-specific Th1-type immune response and CTL effects following intranasal immunization. Cell Mol Immunol. 2011;8(6):496\u2013501. https:\/\/doi.org\/10.1038\/cmi.2011.24.","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"9598_CR25","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/iub.1503","volume":"68","author":"G Mardani","year":"2016","unstructured":"Mardani G, Bolhassani A, Agi E, Shahbazi S, Mehdi SS. Protein vaccination with HPV16 E7\/Pep-1 nanoparticles elicits a protective T-helper cell-mediated immune response. IUBMB Life. 2016;68(6):459\u201367. https:\/\/doi.org\/10.1002\/iub.1503.","journal-title":"IUBMB Life"},{"issue":"2","key":"9598_CR26","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1089\/vim.2021.0143","volume":"35","author":"A Rezaei","year":"2022","unstructured":"Rezaei A, Shahabi G, Faezi S, ShafieeArdestani M, Shirzad H, Azadmanesh K, et al. Adjuvant effects of PSEUDOMONAS aeruginosa Flagellin on the Immunological Patterns of the HIV-1 Vaccine Candidate: Vaccine Formulations Versus Different Routes of Immunization. Viral Immunol. 2022;35(2):150\u20138. https:\/\/doi.org\/10.1089\/vim.2021.0143.","journal-title":"Viral Immunol"},{"issue":"9","key":"9598_CR27","first-page":"1003","volume":"19","author":"M Yasaghi","year":"2016","unstructured":"Yasaghi M, Mahdavi M. Potentiation of human papilloma vaccine candidate using naloxone\/alum mixture as an adjuvant: increasing immunogenicity of HPV-16E7d vaccine. Iran J Basic Med Sci. 2016;19(9):1003\u20139.","journal-title":"Iran J Basic Med Sci"},{"key":"9598_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.biologicals.2017.04.001","volume":"47","author":"S Faezi","year":"2017","unstructured":"Faezi S, Bahrmand AR, Mahdavi M, Siadat SD, Sardari S, Nikokar I, et al. Preparation of Pseudomonas aeruginosa alginate-flagellin immunoconjugate. Biol\u202f: J Int Assoc Biol Stand. 2017;47:11\u20137. https:\/\/doi.org\/10.1016\/j.biologicals.2017.04.001.","journal-title":"Biol : J Int Assoc Biol Stand"},{"key":"9598_CR29","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.micpath.2018.07.042","volume":"123","author":"S Bakht Azad","year":"2018","unstructured":"Bakht Azad S, Nikokar I, Faezi S, Rasooly S, Mahdavi M. Evaluation of the immune responses following co-administration of PilQ and type b-flagellin from Pseudomonas aeruginosa in the burn mouse model. Microb Pathog. 2018;123:426\u201332. https:\/\/doi.org\/10.1016\/j.micpath.2018.07.042.","journal-title":"Microb Pathog"},{"key":"9598_CR30","volume-title":"The QIA Expressionist: A Handbook for High-level Expression and Purification of 6\u00d7 His-tagged Proteins","author":"I Qiagen","year":"2003","unstructured":"Qiagen I, Valencia C. The QIA Expressionist: A Handbook for High-level Expression and Purification of 6\u00d7 His-tagged Proteins. Chatsworth, CA: Qiagen Inc; 2003."},{"key":"9598_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.vascn.2015.05.012","volume":"74","author":"J \u0160evc","year":"2015","unstructured":"\u0160evc J, Matia\u0161ov\u00e1 A, Smolekov\u00e1 I, Jend\u017eelovsk\u00fd R, Mike\u0161 J, Tom\u00e1\u0161ov\u00e1 L, et al. Peroral administration of 5-bromo-2-deoxyuridine in drinking water is not a reliable method for labeling proliferating S-phase cells in rats. J Pharmacol Toxicol Methods. 2015;74:33\u20139.","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"17","key":"9598_CR32","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1016\/j.vaccine.2006.02.022","volume":"24","author":"TA Barr","year":"2006","unstructured":"Barr TA, Carlring J, Heath AW. Co-stimulatory agonists as immunological adjuvants. Vaccine. 2006;24(17):3399\u2013407.","journal-title":"Vaccine"},{"issue":"5","key":"9598_CR33","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1159\/000362367","volume":"6","author":"RMS Gonzalez","year":"2014","unstructured":"Gonzalez RMS, Shehata H, O\u2019connell MJ, Yang Y, Moreno-Fernandez ME, Chougnet CA, et al. Toxoplasma gondii-derived profilin triggers human toll-like receptor 5-dependent cytokine production. J Innate Immun. 2014;6(5):685\u201394.","journal-title":"J Innate Immun"},{"issue":"5","key":"9598_CR34","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00005-019-00551-8","volume":"67","author":"F Blanco-P\u00e9rez","year":"2019","unstructured":"Blanco-P\u00e9rez F, Papp G, Goretzki A, M\u00f6ller T, Anzaghe M, Sch\u00fclke S. Adjuvant allergen fusion proteins as novel tools for the treatment of type I allergies. Arch Immunol Ther Exp. 2019;67(5):273\u201393.","journal-title":"Arch Immunol Ther Exp"},{"key":"9598_CR35","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.foodhyd.2014.10.017","volume":"45","author":"B Delavari","year":"2015","unstructured":"Delavari B, Saboury AA, Atri MS, Ghasemi A, Bigdeli B, Khammari A, et al. Alpha-lactalbumin: A new carrier for vitamin D3 food enrichment. Food Hydrocoll. 2015;45:124\u201331.","journal-title":"Food Hydrocoll"},{"issue":"3","key":"9598_CR36","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1586\/14760584.2015.966085","volume":"14","author":"KA Martins","year":"2015","unstructured":"Martins KA, Bavari S, Salazar AM. Vaccine adjuvant uses of poly-IC and derivatives. Expert Rev Vaccines. 2015;14(3):447\u201359.","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"9598_CR37","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.biopha.2011.03.001","volume":"65","author":"M Mahdavi","year":"2011","unstructured":"Mahdavi M, Davoodi J, Zali MR, Foroumadi A. Concomitant activation of caspase-9 and down-regulation of IAP proteins as a mechanism of apoptotic death in Hep G2, T47D and HCT-116 cells upon exposure to a derivative from 4-aryl-4H-chromenes family. Biomed Pharmacother. 2011;65(3):175\u201382.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"9598_CR38","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s12272-016-0880-z","volume":"40","author":"Y-Y Cho","year":"2017","unstructured":"Cho Y-Y. RSK2 and its binding partners in cell proliferation, transformation and cancer development. Arch Pharmacal Res. 2017;40(3):291\u2013303.","journal-title":"Arch Pharmacal Res"},{"issue":"1","key":"9598_CR39","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.molimm.2012.11.002","volume":"54","author":"MRA Karam","year":"2013","unstructured":"Karam MRA, Oloomi M, Mahdavi M, Habibi M, Bouzari S. Assessment of immune responses of the flagellin (FliC) fused to FimH adhesin of uropathogenic Escherichia coli. Mol Immunol. 2013;54(1):32\u20139.","journal-title":"Mol Immunol"},{"issue":"8","key":"9598_CR40","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.vaccine.2012.12.059","volume":"31","author":"MRA Karam","year":"2013","unstructured":"Karam MRA, Oloomi M, Mahdavi M, Habibi M, Bouzari S. Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice. Vaccine. 2013;31(8):1210\u20136.","journal-title":"Vaccine"},{"issue":"2","key":"9598_CR41","doi-asserted-by":"publisher","first-page":"e1081328","DOI":"10.1080\/2162402X.2015.1081328","volume":"5","author":"SE Lee","year":"2016","unstructured":"Lee SE, Hong SH, Verma V, Lee YS, Duong T-MN, Jeong K, et al. Flagellin is a strong vaginal adjuvant of a therapeutic vaccine for genital cancer. Oncoimmunology. 2016;5(2):e1081328.","journal-title":"Oncoimmunology"},{"issue":"37","key":"9598_CR42","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1016\/j.vaccine.2013.06.054","volume":"31","author":"CT Nguyen","year":"2013","unstructured":"Nguyen CT, Hong SH, Sin J-I, Vu HVD, Jeong K, Cho KO, et al. Flagellin enhances tumor-specific CD8+ T cell immune responses through TLR5 stimulation in a therapeutic cancer vaccine model. Vaccine. 2013;31(37):3879\u201387.","journal-title":"Vaccine"},{"issue":"6","key":"9598_CR43","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/eji.200323919","volume":"33","author":"K Schwarz","year":"2003","unstructured":"Schwarz K, Storni T, Manolova V, Didierlaurent A, Sirard JC, R\u00f6thlisberger P, et al. Role of Toll-like receptors in costimulating cytotoxic T cell responses. Eur J Immunol. 2003;33(6):1465\u201370. https:\/\/doi.org\/10.1002\/eji.200323919.","journal-title":"Eur J Immunol"},{"key":"9598_CR44","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.3389\/fimmu.2017.01988","volume":"8","author":"SL Sanos","year":"2018","unstructured":"Sanos SL, Kassub R, Testori M, Geiger M, P\u00e4tzold J, Giessel R, et al. NLRC4 inflammasome-driven immunogenicity of a recombinant MVA mucosal vaccine encoding flagellin. Front Immunol. 2018;8:1988.","journal-title":"Front Immunol"},{"key":"9598_CR45","first-page":"901817","volume":"2015","author":"S Chen","year":"2015","unstructured":"Chen S, Zheng D, Li C, Zhang W, Xu W, Liu X, et al. Protection against multiple subtypes of influenza viruses by virus-like particle vaccines based on a hemagglutinin conserved epitope. BioMed Res Int. 2015;2015:901817.","journal-title":"BioMed Res Int"},{"issue":"10","key":"9598_CR46","doi-asserted-by":"publisher","first-page":"4984","DOI":"10.4049\/jimmunol.171.10.4984","volume":"171","author":"S Agrawal","year":"2003","unstructured":"Agrawal S, Agrawal A, Doughty B, Gerwitz A, Blenis J, Van Dyke T, et al. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J Immunol. 2003;171(10):4984\u20139.","journal-title":"J Immunol"},{"issue":"6","key":"9598_CR47","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/eji.201041089","volume":"41","author":"S Bobat","year":"2011","unstructured":"Bobat S, Flores-Langarica A, Hitchcock J, Marshall JL, Kingsley RA, Goodall M, et al. Soluble flagellin, FliC, induces an Ag-specific Th2 response, yet promotes T-bet-regulated Th1 clearance of Salmonella typhimurium infection. Eur J Immunol. 2011;41(6):1606\u201318.","journal-title":"Eur J Immunol"},{"issue":"11","key":"9598_CR48","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1002\/eji.200425403","volume":"34","author":"AF Cunningham","year":"2004","unstructured":"Cunningham AF, Khan M, Ball J, Toellner KM, Serre K, Mohr E, et al. Responses to the soluble flagellar protein FliC are Th2, while those to FliC on Salmonella are Th1. Eur J Immunol. 2004;34(11):2986\u201395.","journal-title":"Eur J Immunol"},{"issue":"2","key":"9598_CR49","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4103\/0970-2113.63609","volume":"27","author":"SS Deo","year":"2010","unstructured":"Deo SS, Mistry KJ, Kakade AM, Niphadkar PV. Role played by Th2 type cytokines in IgE mediated allergy and asthma. Lung India. 2010;27(2):66\u201371. https:\/\/doi.org\/10.4103\/0970-2113.63609.","journal-title":"Lung India"},{"key":"9598_CR50","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.micpath.2018.02.023","volume":"117","author":"M Habibi","year":"2018","unstructured":"Habibi M, Karam MRA, Bouzari S. Construction and evaluation of the immune protection of a recombinant divalent protein composed of the MrpA from MR\/P fimbriae and flagellin of Proteus mirabilis strain against urinary tract infection. Microb Pathog. 2018;117:348\u201355.","journal-title":"Microb Pathog"},{"issue":"35","key":"9598_CR51","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1016\/j.vaccine.2015.03.082","volume":"33","author":"C-H Lai","year":"2015","unstructured":"Lai C-H, Tang N, Jan J-T, Huang M-H, Lu C-Y, Chiang B-L, et al. Use of recombinant flagellin in oil-in-water emulsions enhances hemagglutinin-specific mucosal IgA production and IL-17 secreting T cells against H5N1 avian influenza virus infection. Vaccine. 2015;33(35):4321\u20139.","journal-title":"Vaccine"},{"issue":"48","key":"9598_CR52","doi-asserted-by":"publisher","first-page":"6132","DOI":"10.1016\/j.vaccine.2008.08.070","volume":"26","author":"DY Bargieri","year":"2008","unstructured":"Bargieri DY, Rosa DS, Braga CJ, Carvalho BO, Costa FT, Esp\u00edndola NM, et al. New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin. Vaccine. 2008;26(48):6132\u201342.","journal-title":"Vaccine"},{"key":"9598_CR53","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jbiotec.2014.01.037","volume":"175","author":"NS Savar","year":"2014","unstructured":"Savar NS, Jahanian-Najafabadi A, Mahdavi M, Shokrgozar MA, Jafari A, Bouzari S. In silico and in vivo studies of truncated forms of flagellin (FliC) of enteroaggregative Escherichia coli fused to FimH from uropathogenic Escherichia coli as a vaccine candidate against urinary tract infections. J Biotechnol. 2014;175:31\u20137.","journal-title":"J Biotechnol"},{"issue":"50","key":"9598_CR54","doi-asserted-by":"publisher","first-page":"6335","DOI":"10.1016\/j.vaccine.2016.10.066","volume":"34","author":"G Won","year":"2016","unstructured":"Won G, Lee JH. Multifaceted immune responses and protective efficacy elicited by a recombinant autolyzed Salmonella expressing FliC flagellar antigen of F18+ Escherichia coli. Vaccine. 2016;34(50):6335\u201342.","journal-title":"Vaccine"},{"issue":"1","key":"9598_CR55","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12192-010-0219-5","volume":"16","author":"N Pakravan","year":"2011","unstructured":"Pakravan N, Hashemi SM, Hassan ZM. Adjuvant activity of GP96 C-terminal domain towards Her2\/neu DNA vaccine is fusion direction-dependent. Cell Stress Chaperones. 2011;16(1):41\u20138.","journal-title":"Cell Stress Chaperones"},{"issue":"1","key":"9598_CR56","first-page":"141","volume":"160","author":"L Pishraft-Sabet","year":"2015","unstructured":"Pishraft-Sabet L, Kosinska AD, Rafati S, Bolhassani A, Taheri T, Memarnejadian A, et al. Enhancement of HCV polytope DNA vaccine efficacy by fusion to an N-terminal fragment of heat shock protein gp96. Adv Virol. 2015;160(1):141\u201352.","journal-title":"Adv Virol"},{"key":"9598_CR57","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1146\/annurev-immunol-032712-095910","volume":"31","author":"JS Blum","year":"2013","unstructured":"Blum JS, Wearsch PA, Cresswell P. Pathways of antigen processing. Annu Rev Immunol. 2013;31:443\u201373. https:\/\/doi.org\/10.1146\/annurev-immunol-032712-095910.","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"9598_CR58","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1002\/eji.201040421","volume":"40","author":"M Vijay-Kumar","year":"2010","unstructured":"Vijay-Kumar M, Carvalho FA, Aitken JD, Fifadara NH, Gewirtz AT. TLR5 or NLRC4 is necessary and sufficient for promotion of humoral immunity by flagellin. Eur J Immunol. 2010;40(12):3528\u201334. https:\/\/doi.org\/10.1002\/eji.201040421.","journal-title":"Eur J Immunol"},{"issue":"4","key":"9598_CR59","doi-asserted-by":"publisher","first-page":"153","DOI":"10.15430\/jcp.2018.23.4.153","volume":"23","author":"HH Jang","year":"2018","unstructured":"Jang HH. Regulation of Protein Degradation by Proteasomes in Cancer. J Cancer Prev. 2018;23(4):153\u201361. https:\/\/doi.org\/10.15430\/jcp.2018.23.4.153.","journal-title":"J Cancer Prev"},{"key":"9598_CR60","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/978-1-59745-406-3_14","volume":"463","author":"A von Mikecz","year":"2008","unstructured":"von Mikecz A, Chen M, Rockel T, Scharf A. The nuclear ubiquitin-proteasome system: visualization of proteasomes, protein aggregates, and proteolysis in the cell nucleus. Methods Mol Biol. 2008;463:191\u2013202. https:\/\/doi.org\/10.1007\/978-1-59745-406-3_14.","journal-title":"Methods Mol Biol"},{"key":"9598_CR61","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fimmu.2013.00114","volume":"4","author":"S Awate","year":"2013","unstructured":"Awate S, Babiuk LA, Mutwiri G. Mechanisms of action of adjuvants. Front Immunol. 2013;4:114.","journal-title":"Front Immunol"},{"issue":"11","key":"9598_CR62","doi-asserted-by":"publisher","first-page":"6255","DOI":"10.4049\/jimmunol.1001855","volume":"186","author":"JT Bates","year":"2011","unstructured":"Bates JT, Graff AH, Phipps JP, Grayson JM, Mizel SB. Enhanced antigen processing of flagellin fusion proteins promotes the antigen-specific CD8+ T cell response independently of TLR5 and MyD88. J Immunol. 2011;186(11):6255\u201362.","journal-title":"J Immunol"},{"issue":"5","key":"9598_CR63","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.vaccine.2009.11.003","volume":"28","author":"CJM Braga","year":"2010","unstructured":"Braga CJM, Massis LM, Sbrogio-Almeida ME, Alencar BCG, Bargieri DY, Boscardin SB, et al. CD8+ T cell adjuvant effects of Salmonella FliCd flagellin in live vaccine vectors or as purified protein. Vaccine. 2010;28(5):1373\u201382. https:\/\/doi.org\/10.1016\/j.vaccine.2009.11.003.","journal-title":"Vaccine"},{"issue":"9","key":"9598_CR64","doi-asserted-by":"publisher","first-page":"e373-e","DOI":"10.1038\/emm.2017.172","volume":"49","author":"IA Hajam","year":"2017","unstructured":"Hajam IA, Dar PA, Shahnawaz I, Jaume JC, Lee JH. Bacterial flagellin\u2014a potent immunomodulatory agent. Exp Mol Med. 2017;49(9):e373-e. https:\/\/doi.org\/10.1038\/emm.2017.172.","journal-title":"Exp Mol Med"},{"issue":"5","key":"9598_CR65","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/nrd2224","volume":"6","author":"AW Purcell","year":"2007","unstructured":"Purcell AW, McCluskey J, Rossjohn J. More than one reason to rethink the use of peptides in vaccine design. Nat Rev Drug Discovery. 2007;6(5):404\u201314. https:\/\/doi.org\/10.1038\/nrd2224.","journal-title":"Nat Rev Drug Discovery"},{"issue":"1","key":"9598_CR66","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41541-021-00330-7","volume":"6","author":"B Nguyen","year":"2021","unstructured":"Nguyen B, Tolia NH. Protein-based antigen presentation platforms for nanoparticle vaccines. npj Vaccines. 2021;6(1):70. https:\/\/doi.org\/10.1038\/s41541-021-00330-7.","journal-title":"npj Vaccines"},{"key":"9598_CR67","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jconrel.2015.10.038","volume":"240","author":"VN Podust","year":"2016","unstructured":"Podust VN, Balan S, Sim B-C, Coyle MP, Ernst U, Peters RT, et al. Extension of in vivo half-life of biologically active molecules by XTEN protein polymers. J Control Release. 2016;240:52\u201366. https:\/\/doi.org\/10.1016\/j.jconrel.2015.10.038.","journal-title":"J Control Release"},{"key":"9598_CR68","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3389\/fimmu.2020.00283","volume":"11","author":"K Saylor","year":"2020","unstructured":"Saylor K, Gillam F, Lohneis T, Zhang C. Designs of antigen structure and composition for improved protein-based vaccine efficacy. Front Immunol. 2020;11:283.","journal-title":"Front Immunol"},{"issue":"6","key":"9598_CR69","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3390\/vaccines9060563","volume":"9","author":"L Lu","year":"2021","unstructured":"Lu L, Duong VT, Shalash AO, Skwarczynski M, Toth I. Chemical Conjugation Strategies for the Development of Protein-Based Subunit Nanovaccines. Vaccines. 2021;9(6):563.","journal-title":"Vaccines"},{"issue":"2","key":"9598_CR70","doi-asserted-by":"publisher","first-page":"e0148497","DOI":"10.1371\/journal.pone.0148497","volume":"11","author":"M Krupka","year":"2016","unstructured":"Krupka M, Masek J, Barkocziova L, TuranekKnotigova P, Kulich P, Plockova J, et al. The Position of His-Tag in Recombinant OspC and Application of Various Adjuvants Affects the Intensity and Quality of Specific Antibody Response after Immunization of Experimental Mice. PLoS ONE. 2016;11(2):e0148497. https:\/\/doi.org\/10.1371\/journal.pone.0148497.","journal-title":"PLoS ONE"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09598-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-025-09598-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09598-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T08:03:26Z","timestamp":1770192206000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-025-09598-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9598"],"URL":"https:\/\/doi.org\/10.1007\/s12026-025-09598-6","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"23 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any human clinical trial results. The present work contains animal study and it was approved by the Ethics committee of Pasteur Institute of Iran and all experiments were performed according to the Animal Care and use Protocol of Pasteur Institute of Iran.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}